A NEW STABILITY INDICATING UPLC METHOD FOR THE DETERMINATION OF TWO ANTIDIABETIC DRUGS IN COMBINATION: APPLICATIONS TO BULK AND TABLET FORMULATION

Authors

  • A. KRISHNAMANJARI PAWAR A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India
  • TAREKEGN TADESSE UNADE A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India https://orcid.org/0000-0002-7137-6756

DOI:

https://doi.org/10.22159/ijap.2022v14i4.44774

Keywords:

Gliclazide, Metformin, Stability-indicating, UPLC

Abstract

Objective: This work was intended to develop a rapid and sensitive stability-indicating ultra-performance liquid chromatographic (UPLC) method for the determination of Metformin and Gliclazide simultaneously in their pharmaceutical bulk and tablet formulation.

Methods: Separation was performed on Lunna C18 (100 mm x 2.6 mm, 1.6µ) column by using trifluoroacetic acid buffer: acetonitrile (70: 30, v/v) as a mobile phase at a flow rate of 1ml/min and a wavelength of detection of 227 nm. Method validation and forced degradation studies were conducted per the respective guidelines of the International Conference on Harmonization.

Results: Retention times under the optimized condition were 1.719 min and 2.845 min for Metformin and Gliclazide respectively. Linearity ranged between 25.0-375.0 µg/ml for Metformin and 4.0-60.0 µg/ml for Gliclazide with a coefficient of determinations (r2) of greater than 0.99. The limit of detection values was 0.25 µg/ml for Metformin and 0.04 µg/ml for Gliclazide. Recovery results ranged from 99.63 - 101.23 %, and the % RSDs for the precision studies were less than 1.11% for both drugs. The % degradations at various stress conditions ranged from 14.0-5.0% for Metformin and 13.3-2.4% for Gliclazide. The analyte peaks were clearly resolved from the degradant peaks in forced degradation studies.

Conclusion: A fast, sensitive and efficient ultra-performance liquid chromatographic method was successfully developed and validated for the concurrent estimation of Metformin and Gliclazide in their combination, and thus the proposed method can be effectively applied for routine quality control works.

Downloads

Download data is not yet available.

References

International Diabetic Federation [Internet]. Type 2 diabetes. Available from: https://www.idf.org/aboutdiabetes/type-2-diabetes.html. [Last Accessed on 15 Nov 2021].

Chaudhury A, Duvoor C, Dendi VS, Kraleti S, Chada A, Ravilla R, Marco A, Shekhawat NS, Montales MT, Kuriakose K, Sasapu A, Beebe A, Patil N, Musham CK, Lohani GP, Mirza W. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes mellitus.Front Endocrinol.2017 Jan 24;8(6):1-12.doi: 10.3389/fendo.2017.00006,PMID: 28167928.

Alhadramy MS. Diabetes and oral therapies: A review of oral therapies for diabetes mellitus. J. Taibah Univ. Medical Sci.2016 Mar 21;11(4):317-29.

Lavernia F, Adkins SE, Shubrook JH. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgrad Med. 2015 Oct 6 ;127(8):808 –17. doi: 10.1080/00325481.2015.1085293,PMID: 26439384

Li J, Lian H. Recent development of single preparations and fixed-dose combination tablets for the treatment of noninsulin-dependent diabetes mellitus: A comprehensive summary for antidiabetic drugs. Arch Pharm Res. 2016 May 26;39(6):731-46. doi: 10.1007/s12272-016-0762-4, PMID 27230777.

Pareek A, Chandurkar N, Zawar S, Agrawal N. Evaluation of Efficacy and Tolerability of Gliclazide and Metformin Combination: A Multicentric Study in Patients With Type 2 Diabetes Mellitus Uncontrolled on Monotherapy With Sulfonylurea or Metformin. Am J Ther. 2010 Nov-Dec; 17(6):559–65. doi: 10.1097/MJT.0b013e3181c6c0f9,PMID: 20093927

Gottwald-Hostalek U, Schlachter J, Geloneze B. Combination Therapy with Metformin plus Gliclazide in Patients with Type 2 Diabetes. J Diabetes Res Ther. 2016 Mar 29;2(3):1-6. doi :10.16966/2380-5544.119.

Aleti R, Baratam SR, Jagirapu B, Kudamala S. Formulation and evaluation of metformin hydrochloride and gliclazide sustained release bilayer tablets: A combination therapy in management of diabetes. Int J App Pharm. 2021 Sep 07;13(5):60-72.doi: 10.22159/ijap.2021v13i5.41339

Song R. Mechanism of metformin: A tale of two sites. Diabetes Care. 2016 Feb 01; 39(2):187-89. doi: 10.2337/dci15-0013, PMID 26798149.

Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017 Aug 03;60(9):1577-85. doi: 10.1007/s00125-017-4342-z, PMID 28776086.

Palmer KJ, Brogden RN. Gliclazide: An Update of its Pharmacological Properties and Therapeutic Efficacy in Non-Insulin-Dependent Diabetes Mellitus. Drugs 1993 Jul; 46 (1):92-125.doi: 10.2165/00003495-199346010-00007,PMID: 7691511.

Sarkar A, Tiwari A, Bhasin PS, Mitra M. Pharmacological and Pharmaceutical Profile of Gliclazide: A Review. J App Pharm Sci. 2011;01(09):11-19

Jayapala Reddy K, Krishna Mohan G. Comparative antidiabetic activity of marketed Gliclazide formulation with Gliclazide loaded pellets containing gum kondagogu as a drug retarding material in rats. Asian J. Pharm. Clin. Res. 2013 Nov 01;6(5):73-75.

Dhabale PN, Seervi CR. Simultaneous UV Spectrophotometric Method for Estimation of Gliclazide and Metformine Hydrochloride in Tablet Dosage Form. Int. J. Chemtech Res. 2010;2(2):813-7.

Dadhania KP, Nadpara PA ,Agrawal YK. Development and validation of a spectrophotometric method for simultaneous estimation of Gliclazide and Metformin hydrochloride in bulk and tablet dosage form by simultaneous equation method. Int. J. Pharm. Sci. Res. 2011 Jun 01; 2(6): 1559-63.doi:10.13040/IJPSR.0975-8232.2(6).1559-63

Fatema K, Rahman Z, Haque T, Azad MA, Reza S. Development and Validation of a Simple Method for Simultaneous Estimation of Metformin Hydrochloride and Gliclazide in Tablets by using Reversed Phase High Performance Liquid Chromatography. Dhaka Univ. J. Pharm. Sci. 2010; 9(2): 83-9.doi:10.3329/dujps.v9i2.7884.

Goud ESK, Reddy VK, Sekhar CK. A new simple RP – HPLC method for simultaneous estimation of metformin HCl and gliclazide tablet dosage form. Int. J. Pharm. Biol. Sci. 2012;2(4): 277-83.

Nirupamam D, Venkateswar Rao P, Thangabalan B, Babu SM. Development and validation of RP-HPLC method for simultaneous estimation of Gliclazide and Metformin in pure and tablet dosage form. Int J Pharm& Anal Res. 2014;3(4):326-33.

Pawar J, Sonawane S, Chhajed S, Kshirsagar S. Development and Validation of RP-HPLC method for simultaneous Estimation of Metformin HCl and Gliclazide. Asian J. Pharm. Anal. 2016; 6(3):151-4.doi: 10.5958/2231-5675.2016.00024.7.

Gedawy A , Al-Salami H ,Dass CR. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J Food Drug Anal . 2019;27(1):315-22.doi: 10.1016/j.jfda.2018.06.007,PMID: 30648585.

Al-Bathish AY, Gazy AA, El-Jamal MK. RP-HPLC and chemometric methods for the determination of two antidiabetic mixtures; metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci. 2020 Feb 01;12(2):83-94. doi:10.22159/ijpps.2020v12i2.35415.

Patil V, Kale S, Sahare P, Vithalda S. Simultaneous HPTLC analysis of Gliclazide and Metformin hydrochloride in bulk and tablet dosage form. J sci innov res. 2014; 3(3): 325-31.

Ranetti M, Ionescu M, Hinescu L, Ionică E, Anuţa V, Ranetti AE, Stecoza CE, Mircioiu C. Validation of a HPLC method for the simultaneous analysis of metformin and gliclazide in human plasma. Farmacia 2009;57(6):728-35.

Meenakshi D, Meenaxi M. A Review on Ultra Performance Liquid Chromatography.Int. j. drug dev. 2013;5(2):29-34.

Nahar L, Onder A, Sarker SD. A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010–2019). Phytochem Anal. 2020 Jul;31(4):413-57. doi: 10.1002/pca.2906,PMID: 31849137.

International Conference on Harmonization. ICH Harmonized tripartite guideline. Validation of analytical procedures: text and methodology. Vol. Q2(R1). Geneva: Switzerland; 2005.

International Conference on Harmonization.ICH Harmonized tripartite guideline. Stability testing of new drug substances and products. Vol. Q1A(R2). Geneva: Switzerland; 2003.

Gurrala S, Raj S, Cvs S, Anumolu PD. Quality-by-design approach for chromatographic analysis of metformin, empagliflozin and linagliptin. J Chromatogr Sci. 2021 Apr 05;59(4):1-27. doi: 10.1093/chromsci/bmab030, PMID 33822920.

Published

07-05-2022

How to Cite

PAWAR, A. K., & UNADE, T. T. (2022). A NEW STABILITY INDICATING UPLC METHOD FOR THE DETERMINATION OF TWO ANTIDIABETIC DRUGS IN COMBINATION: APPLICATIONS TO BULK AND TABLET FORMULATION. International Journal of Applied Pharmaceutics, 14(4). https://doi.org/10.22159/ijap.2022v14i4.44774

Issue

Section

Original Article(s)